Delve into the world of hereditary cancer predisposition syndromes in this session designed to update clinicians on the ins and outs of cancer genetics. Together we learn how to identify patients at high risk, discuss clinical advances in genetic testing, and evaluate the utility of direct-to-consumer genetic testing. We critically analyze the availability and service delivery of genetic testing and share tools to help shape the landscape of your practice.
Continuing Education Instructions and Disclosure Information
Contact hours available until 10/28/2020.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner
Speakers Conflict of Interest Disclosure: There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
After completing this continuing nursing education activity the learner will be able to recognize when urology patients need a referral for cancer genetic counsleing and have resources to faciliatate that referral.